Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Management of Multidrug Resistant Infections in Lung Transplant Recipients with Cystic Fibrosis

Published:2021-12 Issue: Volume:Volume 14 Page:5293-5301
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Vazirani Jaideep,Crowhurst Thomas^ORCID,Morrissey C Orla,Snell Gregory I

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference100 articles.

1. MODIFIER GENETICS: Cystic Fibrosis

2. Cystic fibrosis

3. Nettie Burke SA. The Australian cystic fibrosis data registry annual report, 2019. Monash University, Department of Epidemiology and Preventive Medicine; 2021. Available from: https://www.cysticfibrosis.org.au/getmedia/bcab56d9-5bbe-4b19-9486-85a0ad2c2a21/ACFDR-2019-Annual-Report.pdf.aspx. Accessed June 15, 2021.

4. Survival Benefit of Lung Transplant for Cystic Fibrosis since Lung Allocation Score Implementation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates;Antimicrobial Agents and Chemotherapy;2023-12-14

2. Intrapulmonary Treatment with Mycobacteriophage LysB Rapidly Reduces Mycobacterium abscessus Burden;Antimicrobial Agents and Chemotherapy;2023-06-15

3. Role of bacteriophage therapy for resistant infections in transplant recipients;Current Opinion in Organ Transplantation;2022-10-11

4. Multiresistant organisms: bacteria and beyond;Current Opinion in Organ Transplantation;2022-06

5. Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients;Current Infectious Disease Reports;2022-04-30